Conquering Childhood Arthritis
The Arthritis Foundation works with families to shape new solutions to conquering childhood arthritis.
JA Research
Turning the Tide for Families Living With JA
Too many children live a life restrained by frequent arthritis pain and the detrimental effects the disease can have on their organs and systems. Add the emotional toll childhood arthritis and other rheumatic conditions can take, on top of endless doctors’ visits, and it’s clear that answers and solutions are urgently needed. That’s why the Arthritis Foundation is committed to making sure JA patients and their families are guiding everything we do. This video summarizes our approach.
At the Arthritis Foundation, we believe it’s imperative that research, data and registries all connect to expedite a cure. And better treatments are needed sooner than later.
Personalized medicine — treatment and care based on the specific needs and condition of an individual patient — will eliminate the current trial-and-error approach. The engagement of patients in this quest will help unravel the mysteries of juvenile rheumatic diseases.
The Arthritis Foundation partners with the Childhood Arthritis and Rheumatology Research Alliance (CARRA) to not only fund research for treatment options, but also to activate large-scale efforts that compare the effectiveness of different treatments, both in the short- and long-terms. Our partnership with CARRA ensures that issues important to patients and families guide the direction of research.
CARRA is a nonprofit research organization of more than 500 physicians, researchers and other health care professionals throughout the United States and Canada. Their membership includes more than 90% of the active pediatric rheumatologists in North America.
Our support equips CARRA with the resources to enhance and expand research data collection for new discoveries. Together, we are building a patient registry to help improve and standardize patient care and find cures for the many forms of juvenile arthritis (JA).
Since 2002, the Arthritis Foundation has invested nearly $30 million toward childhood arthritis research, thanks to the generous support of our donors. Donors have fueled special research projects through our annual Juvenile Arthritis Conferences, as well as the Juvenile Idiopathic Arthritis (JIA) Patient-Focused Drug Development meeting co-hosted by the Foundation and CARRA. The results from this meeting bring patient voices to the development of new FDA guidance for JIA research.
Donors also fund a variety of investigator-initiated grants in partnership with CARRA, supporting specific research, training and other components. Investigators can learn more about Arthritis Foundation-funded research opportunities on the CARRA Grants and Funding page.
As part of the Patients, Advocates & Rheumatology Teams Network for Research & Service (PARTNERS), we are working with other consortium members to create a platform where patients and their families can participate in research they feel is most important. When patients and families register with PARTNERS, information is collected about their illness, background and interests, which helps identify specific, meaningful research opportunities. Once registered, they learn about suitable activities within PARTNERS.
These can include:
Personalized medicine — treatment and care based on the specific needs and condition of an individual patient — will eliminate the current trial-and-error approach. The engagement of patients in this quest will help unravel the mysteries of juvenile rheumatic diseases.
The Arthritis Foundation partners with the Childhood Arthritis and Rheumatology Research Alliance (CARRA) to not only fund research for treatment options, but also to activate large-scale efforts that compare the effectiveness of different treatments, both in the short- and long-terms. Our partnership with CARRA ensures that issues important to patients and families guide the direction of research.
CARRA is a nonprofit research organization of more than 500 physicians, researchers and other health care professionals throughout the United States and Canada. Their membership includes more than 90% of the active pediatric rheumatologists in North America.
Our support equips CARRA with the resources to enhance and expand research data collection for new discoveries. Together, we are building a patient registry to help improve and standardize patient care and find cures for the many forms of juvenile arthritis (JA).
Since 2002, the Arthritis Foundation has invested nearly $30 million toward childhood arthritis research, thanks to the generous support of our donors. Donors have fueled special research projects through our annual Juvenile Arthritis Conferences, as well as the Juvenile Idiopathic Arthritis (JIA) Patient-Focused Drug Development meeting co-hosted by the Foundation and CARRA. The results from this meeting bring patient voices to the development of new FDA guidance for JIA research.
Donors also fund a variety of investigator-initiated grants in partnership with CARRA, supporting specific research, training and other components. Investigators can learn more about Arthritis Foundation-funded research opportunities on the CARRA Grants and Funding page.
As part of the Patients, Advocates & Rheumatology Teams Network for Research & Service (PARTNERS), we are working with other consortium members to create a platform where patients and their families can participate in research they feel is most important. When patients and families register with PARTNERS, information is collected about their illness, background and interests, which helps identify specific, meaningful research opportunities. Once registered, they learn about suitable activities within PARTNERS.
These can include:
- Completing online surveys
- Serving on a PARTNERS committee
- Contributing personal experience and skills to projects
- Contributing to research topic ideas and helping write research study questions
- Providing patient perspectives for study designs
- Helping researchers communicate study results in a way that’s easier for patients and families to understand
Live Yes! INSIGHTS
By giving us 10 minutes, you become part of a force that will change the lives of the almost 60 million people with arthritis. Your voice matters.
